stat
For the first time, a World Health Organization committee has recommended the global agency form a working group to explore policies for contending with the high prices of medicines that are considered essential, but unaffordable in many low and middle-income countries.
The suggestion was made in the latest report about treatments to be added to the WHO list of essential medicines. The list, which is updated every two years, contains the most effective, safe and cost‐effective drugs for treating high-priority illnesses and running a functioning health care system. For this reason, the list is influential because many countries consult the list for determining reimbursement.